BRIDGET ANSHUS

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.

Healthcare policies affecting Americans living with diabetes.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.

Healthcare policies affecting Americans living with diabetes.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Healthcare policies affecting Americans living with diabetes.

Healthcare policies affecting Americans living with diabetes, especially during the coronavirus pandemic.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Healthcare policies affecting Americans living with diabetes, especially during the coronavirus pandemic.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act.

Healthcare policies affecting Americans living with diabetes, especially during the coronavirus pandemic.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.

Healthcare policies affecting Americans living with diabetes, especially during the coronavirus pandemic.

Healthcare policies affecting Americans living with diabetes, especially during the coronavirus pandemic.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promotion of legislative language within H.R. 2500, the National Defense Authorization Act of 2020, to ensure that prescription drugs made available to Department of Defense military treatment facilities include labels that are printed and physically accompany the package from which the drug is to be dispensed and such label provides adequate directions for use of such drug.

Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promoting policies that support patient access to therapies.

Promotion of legislative language within H.R. 2500, the National Defense Authorization Act of 2020, to ensure that prescription drugs made available to Department of Defense military treatment facilities include labels that are printed and physically accompany the package from which the drug is to be dispensed and such label provides adequate directions for use of such drug.

Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.

Promoting policies that support patient access to therapies.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Issues relating to increasing patient and provider access to non-opioid approaches for acute pain management.

Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.

Promoting continued access to pharmaceutical printed packaging information.

Promoting continued access to pharmaceutical printed packaging information.

Promoting policies that support patient access to therapies.

Improving access to non-opioid approaches to pain management.

Promoting policies that support patient access to therapies.

Promoting continued access to pharmaceutical printed packaging information.

Improving access to non-opioid approaches to pain management.

Promoting policies that support biopharmaceutical innovation and competition.

Promoting policies that support biopharmaceutical innovation and competition.